164 related articles for article (PubMed ID: 19017294)
1. Inhibition of melanoma brain metastasis by targeting melanotransferrin at the cell surface.
Rolland Y; Demeule M; Fenart L; Béliveau R
Pigment Cell Melanoma Res; 2009 Feb; 22(1):86-98. PubMed ID: 19017294
[TBL] [Abstract][Full Text] [Related]
2. Melanotransferrin induces human melanoma SK-Mel-28 cell invasion in vivo.
Bertrand Y; Demeule M; Michaud-Levesque J; Béliveau R
Biochem Biophys Res Commun; 2007 Feb; 353(2):418-23. PubMed ID: 17196552
[TBL] [Abstract][Full Text] [Related]
3. Stimulation of cell surface plasminogen activation by membrane-bound melanotransferrin: a key phenomenon for cell invasion.
Michaud-Levesque J; Demeule M; Béliveau R
Exp Cell Res; 2005 Aug; 308(2):479-90. PubMed ID: 15936756
[TBL] [Abstract][Full Text] [Related]
4. A new Mr 55,000 surface protein implicated in melanoma progression: association with a metastatic phenotype.
Boukerche H; Baril P; Tabone E; Bérard F; Sanhadji K; Balme B; Wolf F; Perrot H; Thomas L
Cancer Res; 2000 Oct; 60(20):5848-56. PubMed ID: 11059782
[TBL] [Abstract][Full Text] [Related]
5. Identification of distinct changes in gene expression after modulation of melanoma tumor antigen p97 (melanotransferrin) in multiple models in vitro and in vivo.
Suryo Rahmanto Y; Dunn LL; Richardson DR
Carcinogenesis; 2007 Oct; 28(10):2172-83. PubMed ID: 17449903
[TBL] [Abstract][Full Text] [Related]
6. Activation of stat3 in human melanoma promotes brain metastasis.
Xie TX; Huang FJ; Aldape KD; Kang SH; Liu M; Gershenwald JE; Xie K; Sawaya R; Huang S
Cancer Res; 2006 Mar; 66(6):3188-96. PubMed ID: 16540670
[TBL] [Abstract][Full Text] [Related]
7. Directing adenovirus across the blood-brain barrier via melanotransferrin (P97) transcytosis pathway in an in vitro model.
Tang Y; Han T; Everts M; Zhu ZB; Gillespie GY; Curiel DT; Wu H
Gene Ther; 2007 Mar; 14(6):523-32. PubMed ID: 17167498
[TBL] [Abstract][Full Text] [Related]
8. p54nrb is a new regulator of progression of malignant melanoma.
Schiffner S; Zimara N; Schmid R; Bosserhoff AK
Carcinogenesis; 2011 Aug; 32(8):1176-82. PubMed ID: 21642354
[TBL] [Abstract][Full Text] [Related]
9. Cytokeratin expression in malignant melanoma: potential application of in-situ hybridization analysis of mRNA.
Chen N; Gong J; Chen X; Xu M; Huang Y; Wang L; Geng N; Zhou Q
Melanoma Res; 2009 Apr; 19(2):87-93. PubMed ID: 19190520
[TBL] [Abstract][Full Text] [Related]
10. The function of melanotransferrin: a role in melanoma cell proliferation and tumorigenesis.
Dunn LL; Sekyere EO; Suryo Rahmanto Y; Richardson DR
Carcinogenesis; 2006 Nov; 27(11):2157-69. PubMed ID: 16704991
[TBL] [Abstract][Full Text] [Related]
11. Identification of metastasis-associated proteins involved in gallbladder carcinoma metastasis by proteomic analysis and functional exploration of chloride intracellular channel 1.
Wang JW; Peng SY; Li JT; Wang Y; Zhang ZP; Cheng Y; Cheng DQ; Weng WH; Wu XS; Fei XZ; Quan ZW; Li JY; Li SG; Liu YB
Cancer Lett; 2009 Aug; 281(1):71-81. PubMed ID: 19299076
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of MUC15 activates extracellular signal-regulated kinase 1/2 and promotes the oncogenic potential of human colon cancer cells.
Huang J; Che MI; Huang YT; Shyu MK; Huang YM; Wu YM; Lin WC; Huang PH; Liang JT; Lee PH; Huang MC
Carcinogenesis; 2009 Aug; 30(8):1452-8. PubMed ID: 19520792
[TBL] [Abstract][Full Text] [Related]
13. A novel role of interleukin-13 receptor alpha2 in pancreatic cancer invasion and metastasis.
Fujisawa T; Joshi B; Nakajima A; Puri RK
Cancer Res; 2009 Nov; 69(22):8678-85. PubMed ID: 19887609
[TBL] [Abstract][Full Text] [Related]
14. Thrombospondin 2 inhibits metastasis of human malignant melanoma through microenvironment-modification in NOD/SCID/gammaCnull (NOG) mice.
Chijiwa T; Abe Y; Ikoma N; Yamazaki H; Tsukamoto H; Suemizu H; Kawai K; Wakui M; Nishime C; Matsumoto H; Matsuyama M; Mukai M; Ueyama Y; Nakamura M
Int J Oncol; 2009 Jan; 34(1):5-13. PubMed ID: 19082472
[TBL] [Abstract][Full Text] [Related]
15. Gonadotropin-releasing hormone agonists suppress melanoma cell motility and invasiveness through the inhibition of alpha3 integrin and MMP-2 expression and activity.
Moretti RM; Montagnani Marelli M; Mai S; Limonta P
Int J Oncol; 2008 Aug; 33(2):405-13. PubMed ID: 18636163
[TBL] [Abstract][Full Text] [Related]
16. The role of RhoC in growth and metastatic capacity of melanoma.
Boone B; Van Gele M; Lambert J; Haspeslagh M; Brochez L
J Cutan Pathol; 2009 Jun; 36(6):629-36. PubMed ID: 19222696
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of rho-associated kinase signaling prevents breast cancer metastasis to human bone.
Liu S; Goldstein RH; Scepansky EM; Rosenblatt M
Cancer Res; 2009 Nov; 69(22):8742-51. PubMed ID: 19887617
[TBL] [Abstract][Full Text] [Related]
18. In vivo inhibition of angiogenesis by a soluble form of melanotransferrin.
Michaud-Levesque J; Demeule M; Béliveau R
Carcinogenesis; 2007 Feb; 28(2):280-8. PubMed ID: 16857721
[TBL] [Abstract][Full Text] [Related]
19. The role of the membrane-bound tumour antigen, melanotransferrin (p97), in iron uptake by the human malignant melanoma cell.
Richardson DR
Eur J Biochem; 2000 Mar; 267(5):1290-8. PubMed ID: 10691965
[TBL] [Abstract][Full Text] [Related]
20. The melanoma tumor antigen, melanotransferrin (p97): a 25-year hallmark--from iron metabolism to tumorigenesis.
Suryo Rahmanto Y; Dunn LL; Richardson DR
Oncogene; 2007 Sep; 26(42):6113-24. PubMed ID: 17452986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]